12 November 2013 - 14 November 2013
Manila, Phillippines

Our Speakers

Dr. Hoss A Dowlat
Principal Consultant
PharmaBio Consulting
Dr Louis Boon
Chief Scientific Officer
Polpharma Biologics
Dr. Sandy Eisen
Chief Medical Officer, NLS Pharmaceuticals & Former Chief Medical Officer
Teva Pharmaceuticals
Francois-Xavier Frapaise
Biosimilars Development Consultant and Former Senior VP/Chief Scientific Officer
Optimer Pharmaceuticals
Peter Wittner
Senior Consultant
Interpharm Consultancy
Dr. Alex Kudrin
Biopharmaceutical Consultant, Former Vice-President and Head of Global Development
Celltrion Inc

BACK BY DEMAND!

RETURNING! Asia's Leading Biosimilars Summit takes place LIVE ONLINE!

The Biosimilars Market in Asia represents a significant opportunity, and is gaining momentum and prominence as the patents of big branded drugs lapse and cost-cutting initiatives are implemented in the healthcare sector. Asia is poised to position itself as the centre for global biosimilars manufacturing, development and adoption.

This year in 2021, come 18-19 May 2021, we will gather leading industry experts to track progress and updates in the market, whilst providing experiences on how to tackle your biggest concerns and challenges when it comes to biosimilars! Don's miss it!

Are you ready?

However there are several challenges and barriers to the growth which include concerns about the drug safety and efficacy of biosimilars, lack of knowledge on tackling challenges in the manufacturing, clinical development and adoption of biosimilars, commercialisation and market penetration strategies, regulatory concerns and issues concerning interchangeability, substitution and nomenclature.

At the 2021 summit, we will tackle all your conerns and considerations when it comes to BIOSIMILARS!

Key Benefits of attending the 4th Biosimilars Asia Summit 2021

Learn how you can overcome challenges associated with manufacturing and clinical development of biosimilars
Find out the actual pharmacovigilance, safety, quality and efficacy of biosimilars in the pipeline and market
Overcoming commercialization and market access challenges
Find out how healthcare providers and patients think? - How can you improve their perception of biosimilars and improve adoption
How to deal with biologics innovators' response to the emergence of biosimilars
Managing Commercial challenges such as restrictive formularies, contracting, rebates, and other pricing issues
Deal with Legal challenges including extensive patent estates, unresolved questions from BPCIA, and settlements between originator and biosimilar companies
Understand the latest regulations surrounding biosimilars in Asia, Europe and Americas Region
Emerging Trends in Biosimilars - Find out how you and seize the opportunity and adapt accordingly
Case Studies and Project Success - Grasp this unique opportunity to learn from REAL BIOSIMILARS EXPERTS internationally about the state of the market

WHO SHOULD ATTEND?

All Professionals involved in:

Biosimilar/Biologic Pharmaceuticals
Biomedical Product Development and Manufacturing
Regulatory Affairs Professionals
Clinical and Nonclinical Research
Biostatistics and Data Management
Business Development Executives
Marketing and Commercialization Staff involved with biosimilars
Medical Communications/MSLs
Patient Advocacy/Patient Support Programs
Physicians including specialists across therapeutic disciplines
Healthcare Providers & Hospitals
Pharmacists and pharmacy professionals
Payors, pharmacy benefit managers, insurers, health plans

A Live Online Learning & Networking Opportunity!

Email us today at enquiry@equip-global.com to find out more!

Knowledge Center

Visit the Download Centre to access related reports, articles, interviews and other useful resources

Quick Links

Mark your calendar

Tell a colleague

PIC – 40% cash back when you register for an Equip Global Conference or Training Course

The objectives of the PIC Scheme are the same as those of Equip Global. Both support investment in innovation, productivity and continuous training.

If you are a registered business in Singapore, you can enjoy huge huge tax savings in the form of cash payouts and/or tax deductions when you invest in training of employees. Your attendance at any Equip Global conference or training course is eligible for PIC credits, either as a 40% cash refund or 400% tax deduction. We will provide you with full supporting documentation after the event and assist you in getting the claim completed.

Continuous training and upgrading of your employees is key to the success of your organization. What’s more, boost your tax savings and claim 40% of your registration fee by attending an Equip Global conference or training course today. To do so, follow this simple 5 minute process:

Select, register and pay for your conference/training course of your choice
Complete the PIC form which you can download here: http://www.iras.gov.sg/irasHome/uploadedFiles/Quick_Links/Tax_forms/Business_and_employers/Cash%20Payout%20Application%20Form_B2011_final.xls
Attend the event, learn and network with industry peers
File your receipt (which we will email you), record of attendance (which we will provide you at the event) and the completed PIC form with your accounts department which they will submit to IRAS to process the claim. If you do not have an accounts department or need help with the PIC claim, our staff will be very happy to assist.

Take advantage of the PIC scheme to upgrade your skills, gain the latest information in your field of work, and get access to the knowledge that can help drive your organizations’ performance and productivity.

For more information visit http://www.iras.gov.sg/irashome/picredit.aspx. Terms and conditions apply.